NEKO PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-08
micro format · 26 days late
2025
27-08
micro format · 27 days late
2024
30-08
micro format · 30 days late
2023
27-09
micro format · 58 days late
2022
29-08
micro format · 29 days late
2021
31-12
Financial
Weakest financial yearnet €7,097 ▼79.5%
The net result drops to €7,097, the lowest from 2018 to 2025. It recovers the following year.
31-08
micro format · 31 days late
2020
30-09
micro format · 61 days late
2019
31-12
Financial
Highest result from 2018 to 2025net €62,451 ▲293%
The net result of €62,451 is the highest of those years.
31-12
Financial
Equity above €200,000equity €259,508 ▲31.7%
With a profit in every financial year since 2018, equity grows to €259,508.
27-08
micro format · 27 days late
2018
29-08
full format · 29 days late
2016
01-09
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank